Literature DB >> 3493420

Dual-photon bone densitometry in normal Australian women: a cross-sectional study.

N A Pocock, S Eberl, J A Eisman, M G Yeates, P N Sambrook, J Freund, A Duncan.   

Abstract

Osteoporosis is a major health problem in Australia, as it is in most Western societies. Bone mineral density in the spine and femoral neck are accurate indicators of osteopenia and thus useful indicators of the risk of a fracture. Dual-photon absorptiometry is a non-invasive technique that allows the accurate quantitation of bone mineral density in the lumbar vertebrae and proximal femur with a low radiation exposure. The increasing availability of this technique dictates the requirement for "normal" ranges and quality control. We report here lumbar vertebral and proximal femur bone mineral density as measured by dual-photon absorptiometry in 179 normal Australian women. Forearm bone mineral content in these subjects, as measured by single-photon absorptiometry, is also presented. There was a relative stability of lumbar bone mineral density and forearm bone mineral content before the menopause, after which there was an age-related decline. On the other hand, bone mineral density at all three sites in the proximal femur showed an age-related decline throughout adult life. Intraoperator variability in calculated bone mineral density did not exceed 2.3%. The requirement for correct positioning of the patient is illustrated. The data allow statistical analysis and the development of normal ranges. They provide an Australian base against which individual patient values can now be compared.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493420

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

1.  Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers.

Authors:  H Kröger; J Heikkinen; K Laitinen; A Kotaniemi
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

2.  Bone diminution of osteoporotic females at different skeletal sites.

Authors:  C Mautalen; E Vega; G Ghiringhelli; G Fromm
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

3.  Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women.

Authors:  K Laitinen; M Välimäki; P Keto
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

4.  High bone mineral density among perimenopausal women.

Authors:  Janne Pesonen; Joonas Sirola; Marjo Tuppurainen; Jukka Jurvelin; Esko Alhava; Risto Honkanen; Heikki Kröger
Journal:  Osteoporos Int       Date:  2005-06-16       Impact factor: 4.507

5.  Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.

Authors:  V Matkovic; T Jelic; G M Wardlaw; J Z Ilich; P K Goel; J K Wright; M B Andon; K T Smith; R P Heaney
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Peak bone mass and osteoporosis prevention.

Authors:  J A Eisman; P J Kelly; N A Morrison; N A Pocock; R Yeoman; J Birmingham; P N Sambrook
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Prevention of corticosteroid bone loss.

Authors:  P Sambrook; J Birmingham; P Kelly; S Kempler; T Nguyen; N Pocock; J Eisman
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

8.  Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur.

Authors:  E Vega; C Mautalen; H Gómez; A Garrido; L Melo; A O Sahores
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

9.  Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women.

Authors:  H Kröger; M Tuppurainen; R Honkanen; E Alhava; S Saarikoski
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

10.  Risk for developing osteoporosis in untreated premature menopause.

Authors:  A C Bagur; C A Mautalen
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.